Big Pharma Split Corp Class A

TO:PRM Canada Asset Management

Market Cap

$11.88 Million

CA$17.06 Million CAD

Market Cap Rank

#41091 Global

#602 in Canada

Share Price

CA$14.03

Change (1 day)

-2.57%

52-Week Range

CA$10.63 - CA$15.50

All Time High

CA$15.50

Big Pharma Split Corp Class A - Asset Resilience Ratio

Latest as of June 2025: 89.67%

Big Pharma Split Corp Class A (PRM) has an Asset Resilience Ratio of 89.67% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$23.10 Million

Cash + Short-term Investments

Total Assets

CA$25.77 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Big Pharma Split Corp Class A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Big Pharma Split Corp Class A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$23.10 Million	89.67%
Total Liquid Assets	CA$23.10 Million	89.67%

Asset Resilience Insights

Very High Liquidity: Big Pharma Split Corp Class A maintains exceptional liquid asset reserves at 89.67% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.